Skip to content
All articlesSexual Health & Intimacy7 min read
Sexual Health & Intimacy

PT-141 Nasal Spray vs Injection: The 2026 Comparison

How the two ways of taking PT-141 differ, and why one route became the standard.

A confident, relaxed couple sharing a warm, unhurried morning together at home, close and at ease
Image: pru

For PT-141, injection is the route with the steadiest, most predictable absorption, and it's the form behind today's clinical research. Nasal spray was the original version, but developers set it aside after trials showed uneven absorption and blood-pressure spikes. Both deliver bremelanotide, a peptide studied for low sexual desire in women and men. This page compares how each route works, what a physician weighs, and where pru fits in. Looking into your options here is a smart, proactive step.

Which is better, PT-141 nasal spray or injection?

The subcutaneous injection is the route with the most predictable absorption, and it's the one behind PT-141's clinical research and the approved branded product. The nasal spray was the original form, but it was set aside because the amount that reached the bloodstream varied a lot from person to person and dose to dose. Both routes deliver the same peptide, bremelanotide, which is studied for low sexual desire in women and men.

Bottom lineInjection is the standard route because absorption is steadier and easier to dose. Nasal spray exists, but the results are less consistent. PT-141 is a desire and arousal peptide that acts on melanocortin receptors in the brain, not an ED drug that works on blood flow.

How does each route get PT-141 into the body?

Both routes carry the same molecule to the same place, the brain's desire pathways. They just take different paths to get there. PT-141 (bremelanotide) is a melanocortin receptor agonist, which means it acts on signaling in the brain rather than on blood flow in the body.

  • Injection (subcutaneous): a tiny amount is injected under the skin of the abdomen or thigh. The peptide moves steadily into the bloodstream, so the dose that reaches the brain is close to what was given.
  • Nasal spray (intranasal): the peptide is sprayed into the nose, where it's meant to cross the nasal lining. How much actually absorbs depends on mucus, technique, and the moment, so the delivered dose is harder to predict.
PT-141a melanocortin agonistActs on desirepathwaysin the brainDesireand arousalWorks onthe brainNot bloodflow like ED drugs
Illustrative.

PT-141 nasal spray vs injection at a glance

Here's how the two routes compare on the points people ask about most. Figures come from studies of bremelanotide and the approved subcutaneous product; nasal-spray numbers are more variable by design.

FactorNasal spraySubcutaneous injection
Absorption into bloodLower and highly variableHigh and predictable (near complete in studies)
Typical onsetAbout 45 to 90 minutesAbout 30 to 45 minutes
Dose neededHigher, to offset lost absorptionLower, because more reaches the blood
Consistency day to dayLess consistentMore consistent
Regulatory pathOriginal route, not pursued for approvalThe route of the approved product
How it feels to takeNo needleA small under-the-skin injection
PT-141 nasal spray vs subcutaneous injection

Why does the nasal spray absorb less reliably?

The nasal lining is a narrow, moving surface, so how much peptide crosses it changes with mucus, blood flow, and spray technique. In studies, the amount of bremelanotide reaching the bloodstream by the nasal route was both lower and more variable between people than by injection, where absorption was close to complete and steady.

That gap matters in practice. To land the same effect, a nasal dose usually has to be higher than an injected one, and even then the result is harder to predict. The injection removes most of that guesswork, which is a big reason it became the researched standard. If you want the numbers behind a plan, see PT-141 dosage.

Why did injection become the standard route?

Injection became the standard because the original nasal program ran into safety and consistency problems. Bremelanotide was first developed as a nasal spray, but Phase II trials were paused by the FDA in 2007 after some subjects showed raised blood pressure, and the nasal formulation was dropped in 2008. The molecule was then reformulated as a subcutaneous injection, which is the form later studied and approved.

Blood pressurePT-141 can cause a short, usually small rise in blood pressure. The nasal route made that harder to control because absorption spiked unevenly. The injection produced a smaller, more transient change, with the approved product showing an average rise of only a couple of mmHg that faded within hours.

~2 in 3
people who ask us about PT-141 ask about a nasal option
2007
year the nasal trials were paused for blood pressure
Pru estimates; no official count is published. Trial history from public sources.

How do onset and dosing differ between the routes?

Both routes are taken on demand, ahead of intimacy rather than daily. The injection tends to work a little faster and needs a smaller amount because more of it reaches the blood.

  • Injection: the approved subcutaneous product is a single 1.75 mg dose in the abdomen or thigh, taken at least 45 minutes before activity, with no more than one dose in 24 hours.
  • Nasal spray: onset is slower and the effective amount is higher, because a share of each spray never crosses the nasal lining.
  • Timing: both are meant to be used before intimacy, not on a fixed daily schedule.

Compounded PT-141 is prescribed and dosed by a physician for the individual, so a personal plan may differ from the branded numbers above. It is pharmacy-grade compounded medicine, not the branded product, and it should not be treated as the same thing.

Do the routes have different side effects?

The core side effects are similar because it's the same peptide, but the nasal route made one of them, blood-pressure change, harder to keep steady. The most common reported effects with the injectable form are nausea, flushing, injection-site reactions, and headache.

EffectHow often it was reported
NauseaAbout 40%
FlushingAbout 20%
Injection-site reactionAbout 13%
HeadacheAbout 11%
Commonly reported effects with injectable bremelanotide

Nausea is the effect people notice most, and it's usually mild and short. A short-lived rise in blood pressure is expected with either route, which is why a physician reviews your heart and blood-pressure history first. For the full picture, read PT-141 side effects.

Which route is right for you?

For most people the injection is the more predictable choice, which is why it's the researched and prescribed route. A physician confirms whether PT-141 fits you at all, based on your health history, blood pressure, and preferences. With pru, you select the peptide you're interested in, guided by pages like this one, and the physician confirms fit. pru offers PT-141 as a nasal spray.

Who should be carefulPT-141 is not for people with uncontrolled high blood pressure or known cardiovascular disease. This is exactly the kind of thing a physician screens for before anything is prescribed.

Curious about other paths to the same goal? Oxytocin and kisspeptin are also part of the intimacy conversation. See the best peptides for libido and oxytocin for intimacy.

How pru handles PT-141

pru is a telehealth platform for compounded peptides. A licensed physician reviews your intake and confirms fit, and an FDA-regulated 503A pharmacy compounds and fills your PT-141 as a nasal spray. It's pharmacy-grade compounded medicine, prescribed for you, not the branded product and not a research-grade vial from an unlicensed seller.

A confident, relaxed couple sharing a warm, unhurried morning together at home, close and at ease
Image: pru

Pricing is simple. Membership is about $50 a month and funds the platform, physician oversight, and support. The peptide itself is sold separately, at cost, itemized, with no markup on the medicine. Being proactive about your intimacy and vitality is a smart thing to do, and pru exists to make that informed choice the accessible one: licensed physicians, pharmacy-grade medicine, and at-cost pricing in one place. When you're ready, you can see PT-141 on pru, explore oxytocin, or browse the full sexual health and intimacy catalog.

One notePT-141 is studied for desire and arousal, acting on melanocortin receptors in the brain that signal the body's desire and arousal pathways. A physician confirms whether it's appropriate for you.

Common questions

Is PT-141 nasal spray as effective as the injection?
The injection is more predictable. In studies, the nasal route delivered less bremelanotide into the bloodstream and varied more from person to person, so results were harder to reproduce. The injection absorbs steadily, which is why it became the researched and prescribed route.
Why was the PT-141 nasal spray set aside?
Bremelanotide was first developed as a nasal spray, but Phase II trials were paused by the FDA in 2007 after some subjects showed raised blood pressure, and the nasal form was dropped in 2008. The molecule was reformulated as a subcutaneous injection, which is the version later studied and approved.
Does the nasal spray need a higher dose?
Yes. Because a share of each spray never crosses the nasal lining, a nasal dose usually has to be higher than an injected one to reach a similar effect, and even then the result is less consistent.
Which route works faster?
The injection tends to be a little faster, with onset around 30 to 45 minutes, versus roughly 45 to 90 minutes for the nasal spray. Both are taken on demand, ahead of intimacy, not on a daily schedule.
Is compounded PT-141 the same as Vyleesi?
No. Vyleesi is a branded, FDA-approved subcutaneous product. Compounded PT-141 is pharmacy-grade medicine made for you by a 503A pharmacy under a physician's prescription. They share the same peptide but are not the same product and should not be treated as interchangeable.
Does pru offer PT-141 as a nasal spray or injection?
pru offers PT-141 as a nasal spray. It's prescribed and compounded by an FDA-regulated 503A pharmacy after a physician confirms fit. You select the peptide and the physician confirms fit and dose. See PT-141 on pru to start.
Which route has fewer side effects?
The core effects, such as nausea and flushing, are similar because it's the same peptide. The main difference was blood pressure, which the nasal route made harder to keep steady due to uneven absorption. The injection produced smaller, shorter blood-pressure changes in studies.
How does pru keep peptides affordable?
pru runs on an at-cost model. You pay one flat membership, and the medication is passed through at the pharmacy's price with no member markup. Because pru never marks the medication up, we have every reason to push its price down, not up. As pru grows and orders more, we negotiate lower pricing with our partner pharmacies, and those savings go straight to you. Healthcare pricing is usually hidden and inflated; pru is built to sit on your side of it: transparent, at cost, and fighting to make peptides more affordable as we scale.
Do the savings add up if I take more than one peptide?
Yes, and this is where pru's at-cost pricing saves you the most. Because pru never marks the medication up, every vial is priced at cost, so each peptide you add avoids the markup a typical provider builds in. If a physician has you on more than one peptide, or on a stack, that saving repeats on every vial, all under one flat $50 membership instead of a marked-up price on each. The more your protocol includes, the more the difference adds up, which makes doing it the right way a financially responsible choice, not an expensive one.

Want more like this?

Subscribe to get new articles delivered to your inbox. No spam, unsubscribe anytime.

All Articles